PIV and PILE scores predict the clinical outcome in patients with metastatic breast cancer treated with CDK4/6 inhibitors

Surgical oncology
DOI: 10.1007/s10147-025-02770-w Publication Date: 2025-04-21T12:06:07Z
ABSTRACT
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (56)
CITATIONS (0)